Compounds > bendamustine hydrochloride
Page last updated: 2024-08-25

bendamustine hydrochloride and Acquired Nephrogenic Diabetes Insipidus

bendamustine hydrochloride has been researched along with Acquired Nephrogenic Diabetes Insipidus in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Boudreault, JS; Desjardins, A; Feng, X; Le-Nguyen, V; Rioux, JP; Turgeon-Mallette, L; Veilleux, A; Vo, C1
Derman, BA; Gashti, C; Jain, M; McAninch, EA1
Gordon, CE; Sanchorawala, V; Shelton, AC; Stern, L; Uwumugambi, NA1

Other Studies

3 other study(ies) available for bendamustine hydrochloride and Acquired Nephrogenic Diabetes Insipidus

ArticleYear
Bendamustine-induced nephrogenic diabetes insipidus - A case report.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytarabine; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Transplantation, Autologous

2022
Bendamustine-induced nephrogenic diabetes insipidus
.
    Clinical nephrology, 2017, Volume: 87 (2017), Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Diabetes Insipidus, Nephrogenic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Rituximab

2017
Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017, Volume: 69, Issue:2

    Topics: Amyloidosis; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Diabetes Insipidus, Nephrogenic; Humans; Immunoglobulin Light Chains; Male; Middle Aged

2017